Skip to main content
. Author manuscript; available in PMC: 2017 Oct 15.
Published in final edited form as: Cancer Res. 2016 Aug 15;76(20):5933–5944. doi: 10.1158/0008-5472.CAN-16-0346

Figure 4.

Figure 4

Boxplot of percent change from baseline to mid-therapy in TOITN (%TOITN) by final pathologic status, dichotomized as pCR vs. non-pCR. A) in the overall evaluable dataset; B) in the subset of evaluable cases with baseline tumor oxygenation lower than the median value; C) in the subset of evaluable cases with baseline tumor oxygenation greater than the median value.